ADmit Therapeutics S.L.

Overview

Description

The company develops an epigenetic blood test for early Alzheimer's detection using next-generation sequencing to aid diagnosis and accelerate drug discovery.

Website

www.admit-therapeutics.com

Country

• Spain

Sector

• Medical Technologies